Point-of-Care HIV Testing and Early Dolutegravir Use for Infants

Related grants

Same researchers, same institution, same topic, scored first.

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  Tsepamo Next Generation: Optimizing HIV Treatment and Prevention Strategies for Pregnant Women in Botswana

  Roger L Shapiro · $497K · 2025–2030

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens

  Roger L Shapiro · $420K · 2025–2026

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana

  Daniel R. Kuritzkes · $1.3M · 2023–2028

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana

  Daniel R. Kuritzkes · $890K · 2023–2028

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV

  Roger L Shapiro · $762K · 2021–2026

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  Administrative Core

  Roger L Shapiro · $223K · 2021–2026

• NIH · Harvard University D/B/A Harvard School of Public Health48

  Molecular basis of antimalarial drug resistance in Plasmodium vivax

  Manoj T Duraisingh · $96K · 2022–2027

• NIH · Harvard University D/B/A Harvard School of Public Health45

  Methods for Adaptive Randomized Trials in Infectious Disease Research

  Lee Ding · $46K · 2026–2027

• NIH · Harvard University D/B/A Harvard School of Public Health40

  Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patients

  Kristopher Andrew Sarosiek · $355K · 2020–2027

• NIH · Harvard University D/B/A Harvard School of Public HealthReviewed

  In Utero Exposure to Medications for Cardiometabolic Conditions and Risk of Congenital Malformations

  Jeremy Philip Brown · $119K · 2025–2027

• NIH · Harvard University D/B/A Harvard School of Public HealthReviewed

  An intersectional approach to transgender and/or nonbinary college student mental health: The role of gender identity, race/ethnicity, socioeconomic status, and campus policy

  Even Paglisotti · $20K · 2024–2025

• NIH · Harvard University D/B/A Harvard School of Public HealthReviewed

  Elucidating the biological mechanisms underlying the association between EBV and MS in African Americans

  Alberto Ascherio · $764K · 2024–2029

• NIH · Vanderbilt University Medical CenterNot yet scored

  Know your status: A Cluster Randomized Controlled Trial Comparing Healer-initiated HIV Counseling and Testing to Standard of Care

  Carolyn Audet · $242K · 2024–2029

• NIH · Vanderbilt University Medical CenterNot yet scored

  Know your status: A Cluster Randomized Controlled Trial Comparing Healer-initiated HIV Counseling and Testing to Standard of Care

  Carolyn Audet · $327K · 2024–2029

• NIH · University of California, San FranciscoNot yet scored

  Understanding individual- and social network-level factors affecting infant HIV testing to design social network interventions to increase testing of HIV-exposed infants

  Alison B Comfort · $144K · 2021–2026

• NIH · Harvard University D/B/A Harvard School of Public HealthNot yet scored

  Point-of-Care HIV Testing and Early Dolutegravir Use for Infants

  Roger L Shapiro · $50K · 2021–2026

• NIH · Brigham and Women'S Hospital60

  Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention

  Holly Elizabeth Rawizza · $190K · 2022–2028

• NIH · University of Miami Coral GablesReviewed

  Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

  Sannisha K. Dale · $1.0M · 2023–2028